Carcinogenicity of halogenated olefinic and aliphatic hydrocarbons in mice. 1979

B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth

A series of 15 halogenated hydrocarbons of industrial and environmental importance were tested for carcinogenicity by chronic administration by one or more routes in Ha:ICR Swiss mice. Not all compounds were tested by the four routes of administration used. Allyl chloride, 1,2-dibromo-3-chloropropane, and vinylidene chloride were active as skin tumor initiators in the two-stage carcinogenesis assays; phorbol myristate acetate was used as a promoter. 1,2-Dibromoethane was the only compound that induced a significant incidence (p less than 0.05) of skin papillomas, skin carcinomas, and lung tumors by repeated skin application. 1,2-Dichloroethane, 1,1,2,2-tetrabromoethane, and 1,2-dibromo-3-chloropropane induced lung and/or stomach tumors by repeated skin application. Two compounds showed sarcomagenic activity by sc injection; they were cis-1,3-dichloropropene and 2-chloropropanal. By intragastric intubation, 1-chloropropene and 2-chloropropanal induced significant numbers of stomach tumors. Vehicle, no-treatment, and positive control groups were included in these tests. The following compounds were also tested by one or more of the four routes but were inactive by the criteria used; i.e., they showed P = 0.05 or greater than 0.05: trichloroethylene, tetrachloroethylene, hexachlorobutadiene, chloroacetaldehyde, 1-chloropropene oxide (cis and trans), and trichloroethylene oxide.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010212 Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) Papilloma, Squamous Cell,Papillomatosis,Papillomas,Papillomas, Squamous Cell,Papillomatoses,Squamous Cell Papilloma,Squamous Cell Papillomas
D002274 Carcinogens, Environmental Carcinogenic substances that are found in the environment. Environmental Carcinogens
D003043 Cocarcinogenesis The combination of two or more different factors in the production of cancer. Cocarcinogeneses
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D006846 Hydrocarbons, Halogenated Hydrocarbon compounds with one or more HYDROGEN atoms substituted with HALOGENS. Halogenated Hydrocarbons
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
January 1976, La Medicina del lavoro,
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
December 1977, Environmental health perspectives,
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
January 1985, IARC scientific publications,
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
January 1977, Annali dell'Istituto superiore di sanita,
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
January 1980, Developments in toxicology and environmental science,
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
April 1984, Mutation research,
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
April 1984, Deutsche medizinische Wochenschrift (1946),
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
April 1984, Deutsche medizinische Wochenschrift (1946),
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
May 1991, Mutagenesis,
B L Van Duuren, and B M Goldschmidt, and G Loewengart, and A C Smith, and S Melchionne, and I Seldman, and D Roth
April 2003, SAR and QSAR in environmental research,
Copied contents to your clipboard!